Doug Hattendorf

Doug Hattendorf is a seasoned professional with 15 years of experience in synthetic biology and protein engineering, specializing in business development. They served as Director of Business Development at Ginkgo Bioworks, focusing on technical sales for enzyme needs in Pharma and Biotech sectors. Currently, as the Director of Business Development and Alliance Management at GeneFab, they work on optimizing cell and gene therapies. Doug has also held significant roles at TerraVia Holdings, Inc., Codexis, and Zymergen, contributing to advancements in enzyme engineering and protein production. They earned a Ph.D. in Biochemistry and Molecular Biology from the University of Chicago and completed a postdoctoral fellowship at Stanford University.